Introduction: Targetable drug carriers: Present status and a future perspective

Advanced Drug Delivery Reviews

Volumn 21, Issue 2, 1996, Pages 77-80

  Yokoyama, M ^a   Okano, T ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETAXOLOL; DOXORUBICIN; DRUG CARRIER; LEVOBUNOLOL; LIPOSOME; METOPROLOL; POLYMER; PROPRANOLOL; SALBUTAMOL; SOTALOL; TIMOLOL; ZINOSTATIN;

DRUG CONJUGATION; DRUG RELEASE; DRUG TARGETING; DRUG TRANSPORT; LIPOPHILICITY; NONHUMAN; NOTE; PRIORITY JOURNAL;

ANTIGEN-ANTIBODY REACTIONS; CELLS; DRUG THERAPY; MICELLES; MONOCLONAL ANTIBODIES; PHARMACOKINETICS; PHYSIOLOGY; POLYMERS; PROTEINS; TISSUE;

ANTIBODY SPECIFICITY; ENHANCED PERMEABILITY AND RETENTION EFFECT; IN VIVO SELECTIVE DRUG DELIVERY; LIGAND RECEPTOR BINDING; TARGETABLE DRUG CARRIERS; TRANSFERRIN;

CONTROLLED DRUG DELIVERY;

EID: 0030234981     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(96)00439-5     Document Type: Editorial

References (16)

1. H. Maeda L.W. Seymour Y. Miyamoto Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo Bioconju. Chem. 3 1992 351 361
2. T. Konno Y. Kai R. Yamashita A. Nagamitsu M. Kimura Targeted chemotherapy for unresectable primary and metastatic liver cancer Acta Oncol. 33 1994 133 137
3. L.W. Seymour K. Ulbrich P.S. Steyger M. Brereton V. Subr J. Strohalm R. Duncan Br. J. Cancer 70 1994 636 641
4. P.A. Vasay R. Duncan S.B. Kaye J. Cassidy Clinical phase I trial of PK1 (HPMA co-polymer doxorubicin) Eur. J. Cancer. 31A 1995 S193 (supple)
5. B. Uziely S. Jeffers R. Isacson K. Kutsch D. Wei-Tsao Z. Yehoshua E. Libson F.M. Muggia A. Gabizon Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies J. Clin. Oncol. 13 1995 1777 1785
6. P.A. Trail D. Wilner S.J. Lasch A.J. Henderson H. Hofstead A.M. Casazza R.A. Firestone I. Hellström K.E. Hellström Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates Science 261 1993 212 215
7. G.S. Kwon S. Suwa M. Yokoyama T. Okano S. Sakurai K. Kataoka Enhanced tumor accumulation and prolonged circulation times of micelleforming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates J. Contr. Rel. 29 1994 17 23
8. A.A. Gabizon Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes Cancer Res. 52 1992 891 896
9. Y. Matsumura H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
10. Y. Takakura M. Hashida Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution Pharm. Res. 13 1996 820 831
11. K. Kataoka G.S. Kwon M. Yokoyama T. Okano Y. Sakurai Block copolymer micelles as vehicles for drug delivery J. Contr. Rel. 24 1993 119 132
12. M. Yokoyama Block Copolymers as Drug Carriers Critical Reviews in Therapeutic Drug Carrier Systems 9 1992 213 248
13. T. Okano N. Yui M. Yokoyama R. Yoshida Advances in polymeric systems for drug delivery Third Edition I. Karube R. Kuroda Japanese Technology Reviews Vol. 4 1994 Gordon and Breach Science Publishers Yverdon, Switzerland No. 1
14. Cammas, S., Suzuki, K., Sone, C., Sakurai, Y. and Okano, T. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site specific drug carriers. J. Contr. Rel. in press
15. D.D. Lasic F.J. Martin A. Gabizon S.K. Huang D. Papahadjopoulos Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times Biochim. Biophys. Acta. 1070 1991 187 192
16. S.K. Huang P.R. Stauffer K. Hong J.W.H. Uuo T.L. Philips A. Huang D. Papahadjopoulos Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes Cancer Res. 54 1994 2186 2191